Literature DB >> 30132237

Serum or Plasma Matrix Metalloproteinase (MMP)-9 Levels and Cardiovascular Diseases.

Indiara V Santana1, Jose E Tanus-Santos2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30132237     DOI： 10.1007/s12265-018-9827-8

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN： 1937-5387            Impact factor:   4.132


× No keyword cloud information.
  5 in total

1.  Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities.

Authors:  Raquel F Gerlach; Juliana A Uzuelli; Caroline D Souza-Tarla; Jose E Tanus-Santos
Journal:  Anal Biochem       Date:  2005-09-01       Impact factor: 3.365

2.  Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions.

Authors:  Raquel F Gerlach; Cesar A Meschiari; Andrea M Marcaccini; Ana C T Palei; Valeria C Sandrim; Ricardo C Cavalli; Jose E Tanus-Santos
Journal:  Clin Chem Lab Med       Date:  2009       Impact factor: 3.694

Review 3.  Circulating matrix metalloproteinases and their inhibitors in hypertension.

Authors:  Vanessa Fontana; Pamela S Silva; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  Clin Chim Acta       Date:  2012-01-08       Impact factor: 3.786

4.  Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma.

Authors:  Raquel F Gerlach; Caroline Demacq; Klaus Jung; Jose E Tanus-Santos
Journal:  Clin Biochem       Date:  2006-10-19       Impact factor: 3.281

5.  Serum MMP-9 Diagnostics, Prognostics, and Activation in Acute Coronary Syndrome and Its Recurrence.

Authors:  Laura Lahdentausta; Jaakko Leskelä; Alina Winkelmann; Taina Tervahartiala; Timo Sorsa; Erkki Pesonen; Pirkko J Pussinen
Journal:  J Cardiovasc Transl Res       Date:  2018-01-18       Impact factor: 4.132
  5 in total
  3 in total

1.  The Use of Serum MMP-9 and TIMP-1 in Acute Coronary Syndrome.

Authors:  Laura Lahdentausta; Timo Sorsa; Erkki Pesonen; Pirkko Pussinen
Journal:  J Cardiovasc Transl Res       Date:  2018-09-24       Impact factor: 4.132

2.  Correlation Analysis of Acute Coronary Syndrome with Serum IL-18, MMP-9, hs-CRP, and Plasma FIB.

Authors:  Yuexia Yang; Guoming Li; Ruiqin Zhang
Journal:  Biomed Res Int       Date:  2022-01-04       Impact factor: 3.411

3.  Impact of PCSK9 Inhibition on Proinflammatory Cytokines and Matrix Metalloproteinases Release in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque.

Authors:  Marcin Basiak; Michal Kosowski; Marcin Hachula; Boguslaw Okopien
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.